Name: Traceability Implementation Information Session – Digital Systems, Data Exchanges and API Interfaces
Start: 2026-09-11T10:00:00+02:00
End: 2026-09-11T11:30:00+02:00
Location: Virtual

03 Sep Traceability Implementation Information Session – Digital Systems, Data Exchanges and API Interfaces

Posted at 10:13h in

The South African Health Products Regulatory Authority (SAHPRA) invites industry stakeholders to attend an information session on Traceability Implementation: Digital Systems, Data Exchanges and API Interfaces. This session will provide stakeholders with an overview of the digital systems and interoperability requirements that support product traceability across...

frank via Adobe Stock

26 Aug South Africa Maintains WHO Maturity Level 3 (ML3) for Vaccine Regulation

Posted at 16:28h in News & Updates

26 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to share that the World Health Organization (WHO) has confirmed that South Africa has achieved and maintained Maturity Level 3 (ML3) for the regulation of vaccines (producing), as of 18 August...

24 Aug SAHPRA’s Regulatory Technical Forum (RTF) Virtual Meeting – August 2026

Posted at 12:06h in

The South African Health Products Regulatory Authority (SAHPRA) hosted the Regulatory Technical Forum (RTF) Meeting. Recording Presentations...

FAMILY STOCK via Adobe Stock

20 Aug SAHPRA Reaffirms the Safety of Routine Childhood Vaccination

Posted at 22:42h in News & Updates

20 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reaffirm the public that routine childhood vaccines used in South Africa remain safe based on ongoing evidence and monitoring. SAHPRA continuously monitors the safety and quality of vaccines used in South Africa....

20 Aug Webinar on Engagement Portal: New Module Launches

Posted at 10:35h in

The South African Health Products Regulatory Authority (SAHPRA) hosted a webinar on the launch of new modules within the SAHPRA Portal. The webinar provided an overview of newly introduced portal functionalities designed to enhance regulatory processes, improve data quality, and support digital transformation initiatives. Stakeholders received...

TheWaterMeloonProjec via Adobe Stock

19 Aug Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes

Posted at 20:48h in Safety Alerts 1

20 August 2026 The South African Health Products Regulatory Authority (SAHPRA) wishes to remind healthcare professionals of the risk of angioedema during treatment with angiotensin-converting enzyme (ACE) inhibitors (e.g. captopril, enalapril, lisinopril, perindopril, quinapril, ramipril, trandolapril). Healthcare professionals are reminded that ACE inhibitor treatment should be...

17 Aug 2nd Stakeholder Webinar: Further Engagement and Update on Import Authorisation Requirements for Health Products Importers

Posted at 13:36h in

The South African Health Products Regulatory Authority (SAHPRA) remained committed to strengthening the regulation of health products and aligning South Africa's regulatory framework with international best practices. Following the initial stakeholder engagement on the mandatory Import Authorisation System for health products, SAHPRA acknowledged the valuable feedback...

SAHPRA and TUT faculty representatives at the Arcadia Campus

17 Aug SAHPRA inspires TUT students to pursue careers in health regulation

Posted at 09:18h in News & Updates

Pretoria, 17 August 2026 – Tshwane University of Technology (TUT) Faculty of Science students at the Arcadia Campus filled the Science Hall to welcome the South African Health Products Regulatory Authority (SAHPRA) as part of its ongoing programme to engage university students and raise...

Soni's via Adobe Stock

16 Aug SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure

Posted at 20:23h in News & Updates, Press Releases

Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high blood pressure (hypertension), following the identification of out-of-specification results during post-marketing surveillance inspections. The recall...

20 Jul SAHPRA Inspires Rhodes Science Students to Shape the Future of Health Regulation

Posted at 12:00h in News & Updates

Pretoria, 20 July 2026 – Approximately 200 pharmacy and science students at Rhodes University gathered at the University's Makhanda campus, formerly Grahamstown, on 9 July to explore careers in health product regulation during the South African Health Products Regulatory Authority's (SAHPRA) participation in the University's...

SAHPRA Tag